Page last updated: 2024-11-07

1,3-dicapryloylglycerol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-dioctanoylglycerol : A 1,3-diglyceride in which both acyl groups are specified as octanoyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID150911
CHEBI ID136814
SCHEMBL ID3109961
MeSH IDM0163857

Synonyms (31)

Synonym
1,3-dioctanoylglycerol
2-hydroxypropane-1,3-diyl dioctanoate
1,3-dicaprylin
dag(8:0/0:0/8:0)
CHEBI:136814
diacylglycerol (8:0/0:0/8:0)
1,3-dicapryloylglycerol
1429-66-9
dg(8:0/0:0/8:0)
(2-hydroxy-3-octanoyloxypropyl) octanoate
1,3-dcg
octanoic acid, 2-hydroxy-1,3-propanediyl ester
1,3-dogl
einecs 252-992-1
dioctanoic acid, diester with glycerol
glyceryl 1,3-dicaprylate
NEW0U7C3IV
glyceryl-1,3-dicaprylate
SCHEMBL3109961
2-hydroxy-3-octanoyloxy-propyl octanoate
1,3-dioctanoin
2-hydroxy-3-octanoyloxypropyl octanoate
1,3-dioctanoyl glycerol
octanoin, 1,3-di-
glycerol 1,3-dicaprylate
DTXSID40892062
Q27284832
D93150
AS-56521
AKOS037645050
BAA42966
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Brassica napus metaboliteAny plant metabolite that is produced by rapeseed (Brassica napus).
excipientA generally pharmacologically inactive substance that is formulated with the active ingredient of a medication.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
1,3-diglyceride
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]